FDA’s Combo Product GMP Reg Speeds Ahead Unchanged
This article was originally published in The Pink Sheet Daily
Executive Summary
Agency decides to keep the proposed rule, issued in 2009, “largely identical” and denies requests to delay implementation a year.
You may also be interested in...
Device Industry Seeks More Clarity Following Combo Product GMP Final Rule
FDA’s final regulation outlines which manufacturing system requirements apply to products that have drug, device and/or biologic components. The Combination Products Coalition says key details need to be filled in by FDA with guidance.
Industry Seeks More Clarity Following Combo Product GMP Final Rule
FDA’s final regulation outlines which manufacturing system requirements apply to products that have drug, device and/or biologic components. An industry coalition says key details need to be filled in by FDA with guidance.
For Combination Product Development, Industry Says Talk Is Cheap
Industry official says FDA is responsive to questions from sponsors, but should issue more written guidance to help sponsors make development decisions.